Navigation Links
Shire Continues to Deliver Excellent Growth From Core Products
Date:10/30/2009

1,335.2 1,044.4 Non-current assets: Investments 95.2 42.9 Property, plant and equipment, net 630.0 534.2 Goodwill 385.9 350.8 Other intangible assets, net 1,832.9 1,824.9 Deferred tax asset 136.7 118.1 Other non-current assets 11.6 18.4 Total assets 4,427.5 3,933.7 LIABILITIES AND EQUITY Current liabilities: Accounts payable and accrued expenses 938.9 708.6 Deferred tax liability 10.9 10.9 Other current liabilities 124.6 104.3 Total current liabilities 1,074.4 823.8 Non-current liabilities: Convertible bonds 1,100.0 1,100.0 Other long-term debt 43.7 43.1 Deferred tax liability 315.5 377.0 Other non-current liabilities 219.5 291.3 Total liabilities 2,753.1 2,635.2 Shareholders' equity: Common stock of 5p par value; 1,000 million shares authorized; and 561.0 million shares issued and outstanding (2008: 1,000 million shares authorized; and 560.2 million shares issued and outstanding) 55.6 55.5 Additional paid-in capital 2,645.0 2,594.6 Treasury stock: 19.2 million shares (2008: 20.7 million) (375.5) (397.2) Accumulated other comprehensive income 146.6 97.0 Accumulated deficit (797
'/>"/>
SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)...  OrthoSpace Ltd. ("OrthoSpace" or "Company") announced today ... its US Investigational Device Exemption (IDE) pivotal study.  ... blinded control study that compares the Company,s InSpace ... repair for the treatment of full thickness massive ... available outside of the United States ...
(Date:7/6/2015)... , July 6, 2015 /CNW/ - The Canadian Pharmacists Association ... immunization strategy to ensure that all Canadians have the ... HPV (human papillomavirus) through immunization. The lack of access ... Canada is needlessly putting the health ... such as HPV, continue to pose a significant threat ...
(Date:7/6/2015)... 6, 2015 Mauna Kea ... multidisciplinary confocal laser endomicroscopy platform, announced today it ... Ministry of Health, Labor and Welfare (MHLW) ... the AQ-Flex 19 miniprobe.   Used ... miniprobe is comprised of a fiber-optic microscope that ...
Breaking Medicine Technology:OrthoSpace Enrolls First Patients in US IDE Study 2CPhA Calls for HPV Strategy for Young Men to Save Lives 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3
(Date:7/7/2015)... ... ... Connexion Point is holding an onsite job fair to hire 400 people for its new ... this upcoming Wednesday, July 8, and Thursday, July 9, from 9:00 a.m. – 5:00 p.m. ... as well as holding onsite interviews. Interested parties are encouraged to attend the job ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... For ... finding medical providers for personal injury victims. Throughout the company’s history the goal ... deliver the care victims need in their recovery. And while Doctors on Liens ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... System that eliminates 100% of all acids, chemicals and impurities; it also properly ... drinking water because it contains harmful contaminants.  These harmful contaminants are a byproduct ...
(Date:7/6/2015)... ... ... 22, 2015, Fox News in a report titled “ Female Hair Loss Needs to be ... quarter of all women in the U.S. will suffer from thinning hair or hair loss ... One woman, a former beauty queen, who was interviewed for the report began losing her ...
(Date:7/6/2015)... ... July 06, 2015 , ... Hundreds of thousands of ... which is why liposuction regularly ranks among the top five most popular cosmetic ... become more than a way to slim down a silhouette for swimsuit season. ...
Breaking Medicine News(10 mins):Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3
... birth defects, research shows , THURSDAY, Oct. 1 (HealthDay ... give birth to babies with heart defects, a new study ... researchers analyzed data on 6,440 infants with congenital heart defects ... in the National Birth Defects Prevention Study. , Women who ...
... Urges Congress to Pass Relief Legislation for Older Americans - ... Oct. 1 In the midst of dwindling retirement savings ... more bad news that could spell disaster for many - ... Today, AARP announced it will urge Congress to immediately ...
... drugs urged for moms-to-be , THURSDAY, Oct. 1 (HealthDay News) ... from H1N1 swine flu as of the end of August, ... federal health officials said Thursday. , While the officials said ... the number of deaths from the H1N1 flu could be ...
... (WSNA), representing more than 16,000 registered nurses in Washington State, ... System for unilaterally implementing a mandatory vaccination policy. This new ... to wear face masks as a condition of employment and ... comply with the policy. The lawsuit seeks an injunction to ...
... and cardiologists across the country are reaching out to ... preserved as discussions about healthcare reform continue. ... Medicaid Services (CMS) - scheduled to become law January ... life-saving cardiology testing and services currently available in cardiology ...
... System study has found that high-risk surgery patients ... seen by general internists trained in managing medical ... high-risk orthopaedic surgeries experienced shorter stays when their ... And, the study found, patients reported they were ...
Cached Medicine News:Health News:Pre-Pregnancy Weight Linked to Babies' Heart Problems 2Health News:28 Pregnant Women Have Died From Swine Flu: CDC 2Health News:28 Pregnant Women Have Died From Swine Flu: CDC 3Health News:Washington State Nurses Association Seeks Injunction in Federal Court to Block Mandatory Vaccination Policy by MultiCare Health System 2Health News:Proposed Medicare Changes Will Increase Costs to Government, Decrease Options for Patients 2Health News:Proposed Medicare Changes Will Increase Costs to Government, Decrease Options for Patients 3Health News:How to reduce hospital stays and increase patient satisfaction 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: